Oncternal Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.4k | 6.4k | 0.54 |
| 2023-09-30 | $1.9k | 6.4k | 0.30 |
| 2023-06-30 | $2.2k | 6.4k | 0.35 |
| 2022-12-31 | $6.3k | 6.3k | 1.00 |
| 2022-09-30 | $0 | 6.3k | 0.00 |
| 2022-06-30 | $0 | 6.3k | 0.00 |
| 2022-03-31 | $111k | 80k | 1.39 |
| 2021-12-31 | $347k | 153k | 2.27 |
| 2021-09-30 | $1.3M | 318k | 4.17 |
| 2021-06-30 | $514k | 99k | 5.21 |
| 2021-03-31 | $52k | 6.3k | 8.33 |
| 2020-12-31 | $34k | 5.2k | 6.67 |
| 2020-09-30 | $0 | 66 | 0.00 |
| 2020-06-30 | $0 | 61 | 0.00 |
| 2020-03-31 | $0 | 61 | 0.00 |
| 2019-06-30 | $0 | 35 | 0.00 |